MK-0752
CAS No. 471905-41-6
MK-0752 ( MK0752;MK 0752 )
Catalog No. M14568 CAS No. 471905-41-6
A potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 86 | In Stock |
|
5MG | 156 | In Stock |
|
10MG | 234 | In Stock |
|
25MG | 419 | In Stock |
|
50MG | 615 | In Stock |
|
100MG | 876 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-0752
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells.
-
DescriptionA potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells; Notch signaling inhibitor.Breast Cancer Phase 2 Clinical
-
SynonymsMK0752;MK 0752
-
PathwayWnt/Notch/Hedgehog
-
Targetγ-secretase
-
RecptorAβ
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number471905-41-6
-
Formula Weight442.90
-
Molecular FormulaC21H21ClF2O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(O)CC[C@H]1CC[C@](C2=CC(F)=CC=C2F)(S(=O)(C3=CC=C(Cl)C=C3)=O)CC1
-
Chemical NameCyclohexanepropanoic acid, 4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)-, cis-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cook JJ, et al. J Neurosci. 2010 May 12;30(19):6743-50.
2. Previs RA, et al. Clin Cancer Res. 2015 Mar 1;21(5):955-61.
3. Brana I, et al. Br J Cancer. 2014 Nov 11;111(10):1932-44.
2. Previs RA, et al. Clin Cancer Res. 2015 Mar 1;21(5):955-61.
3. Brana I, et al. Br J Cancer. 2014 Nov 11;111(10):1932-44.
molnova catalog
related products
-
BMS-433796
A potent, orally active γ-secretase inhibitor with cell IC50 of 0.3 nM.
-
PF-06648671
PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.
-
MRK-003
A potent γ-secretase inhibitor with IC50 of 0.4 nM, inhibition of Aβ secretion from SH-SY5Y SPA4CT cells.